CAMP
CAMP4 THERAPEUTICS CORPORATIONNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$219.13M
P/E Ratio
—
EPS
$-2.35
Beta
—
52W High
$7.75
52W Low
$1.30
50-Day MA
$4.34
200-Day MA
$4.18
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About CAMP4 THERAPEUTICS CORPORATION
CalAmp Corp. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $3.93M |
| Gross Profit (TTM) | $-34.28M |
| EBITDA | $-50.29M |
| Operating Margin | -1010.00% |
| Return on Equity | -209.30% |
| Return on Assets | -38.70% |
| Revenue/Share (TTM) | $0.10 |
| Book Value | $0.59 |
| Price-to-Book | 7.09 |
| Price-to-Sales (TTM) | 55.70 |
| EV/Revenue | 31.02 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 50.80% |
| Shares Outstanding | $51.93M |
| Float | $26.50M |
| % Insiders | 13.07% |
| % Institutions | 86.62% |
Historical Volatility
HV 10-Day
74.03%
HV 20-Day
84.72%
HV 30-Day
75.34%
HV 60-Day
67.53%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($7.92 target)
1
Strong Buy4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026